Lyme disease - What is the cost for Scotland?

Public Health

Volumn 117, Issue 4, 2003, Pages 264-273

  Joss, A W L ^a   Davidson, M M ^a   Ho Yen, D O ^a   Ludbrook, A ^b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Costs; Lyme disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE;

LYME DISEASE;

ABSENTEEISM; ANAMNESIS; ARTICLE; BORRELIA BURGDORFERI; CLINICAL STUDY; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEVER; FLU LIKE SYNDROME; HEADACHE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; LABORATORY TEST; LYME DISEASE; MAJOR CLINICAL STUDY; MALAISE; MEDICAL INFORMATION; MEDICAL LITERATURE; PATIENT CARE; PROPHYLAXIS; SIDE EFFECT; SYMPTOM; TICK BITE; TIME; UNITED KINGDOM;

EID: 0038421895     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(03)00067-2     Document Type: Article

References (34)

1. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease: a tick-borne spirochetosis? Science 1982;216:1317-9.
2. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. New Engl J Med 1983;308:733-40.
3. Loewen PS, Marra CA, Marra F. Systematic review of the treatment of early Lyme disease. Drugs 1999;57:157-73.
4. Sigal LH. The Lyme disease controversy. Social and financial cost of misdiagnosis and mismanagement. Arch Intern Med 1996;156:1493-500.
5. Shapiro ED, Gerber MA. Lyme disease. Clin Infect Dis 2000; 31:533-42.
6. Maes E, Lecomte P, Ray N. A cost-of-illness study of Lyme disease in the United States. Clin Ther 1998;20:993-1008.
7. Meltzer MI, Dennis DT, Orloski KA. The cost effectiveness of vaccinating against Lyme disease. Emerging Infect Dis 1999; 5:321-8.
8. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. New Engl J Med 1995;333:1319-24.
9. Ho-Yen DO, Davidson MM, Chisholm SM, Joss AWL. How prevalent is Lyme disease in Scotland? Scott Cent Infect Environ Health Wkly Rep 2000;33:214-5.
10. Hassler D, Maiwald M, Petney TN. Diagnosis, treatment and prevention of Lyme disease (letter). J Am Med Assoc 1998; 280:1049-50.
11. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I. Treatment of late Lyme borreliosis. J Infect 1994;29: 255-61.
12. Wormser P, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 2000;31(Suppl. 1):S1-S14.
13. Eckman MH, Steere AC, Kalish RA, Pauker SG. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. New Engl J Med 1997;337:357-63.
14. Davidson MM, Ling CL, Chisholm SM, Wiseman AD, Joss AWL, Ho-Yen DO. Evidence-based diagnosis of Lyme disease. Eur J Clin Microbiol Infect Dis 1999;18:484-9.
15. Davidson MM, Chisholm SM, Wiseman AD, Joss AWL, Ho-Yen DO. Improved serodiagnosis of Lyme disease. J Clin Pathol: Mol Pathol 1996;49:M80-4.
16. Pfister H-W, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994;343:1013-6.
17. Hansen K. Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-1990. Acta Neurolog Scand 1994;89(Suppl. 151):1-44.
18. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000;24:1279-85.
19. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New Engl J Med 2001;345:85-92.
20. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996;23:1392-7.
21. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. J Am Med Assoc 1993;269: 1812-6.
22. Piesman J, Maupin GO, Campos EG, Happ CM. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J Infect Dis 1991; 163:895-7.
23. Information and Statistics Division, NHS Scotland. Scottish Health Service Costs 1999/2000. Edinburgh: Trinity Park House.
24. British Medical Association, Royal Pharmacological Society of Great Britain. British National Formulary 1999. London: BMJ Books.
25. Smyth ETM, Barr JG, O'Neill CA, Hogg GM. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins. Pharm Econ 1995;8:541-50.
26. Office for National Statistics, London, New earnings survey, April 1999. Part E: Regional trends 35. Labour Market 2000; 5:85.
27. Fix AD, Strickland T, Grant J. Tick bites and Lyme disease in an endemic setting. Problematic use of serologic testing and prophylactic antibiotic therapy. J Am Med Assoc 1998;279: 206-10.
28. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323: 1438-44.
29. Nichol G, Dennis DT, Steere AC, et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Intern Med 1998;128: 37-48.
30. Wolfe F, Anderson J. Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997;40:1560-70.
31. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. J Am Med Assoc 2000; 283:609-16.
32. Shapiro ED. Doxycycline for tick bites-not for everyone. N Engl J Med 2001;345:133-4.
33. Magid D, Schwartz B, Craft J, Schwartz JS. Prevention of Lyme disease after tick bites: a cost-effectiveness analysis. N Engl J Med 1992;327:534-41.
34. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin infect Dis 2000;31:1107-9.